tiprankstipranks
Trending News
More News >
Nuvation Bio (NUVB)
NYSE:NUVB
US Market

Nuvation Bio (NUVB) Financial Statements

Compare
754 Followers

Nuvation Bio Financial Overview

Nuvation Bio's market cap is currently $2.01B. The company's EPS TTM is $-0.11; its P/E ratio is -9.12; Nuvation Bio is scheduled to report earnings on March 2, 2026, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 62.90M$ 7.87M$ 0.00$ 0.00$ 0.00
Gross Profit$ 54.46M$ 795.00K$ 0.00$ 0.00$ 0.00
Operating Income$ -213.06M$ -592.63M$ -99.82M$ -119.73M$ -93.32M
EBITDA$ -213.06M$ -566.91M$ -75.58M$ -119.53M$ -93.13M
Net Income$ -204.63M$ -567.94M$ -75.80M$ -104.20M$ -86.85M
Balance Sheet
Cash & Short-Term Investments$ 529.21M$ 502.69M$ 611.21M$ 661.01M$ 765.39M
Total Assets$ 594.82M$ 540.63M$ 621.48M$ 672.14M$ 776.15M
Total Debt$ 10.15M$ 8.91M$ 4.01M$ 4.26M$ 3.06M
Net Debt$ -153.94M$ -26.81M$ -38.64M$ -96.84M$ -129.37M
Total Liabilities$ 289.11M$ 76.84M$ 16.36M$ 17.07M$ 30.15M
Stockholders' Equity$ 305.72M$ 463.79M$ 605.12M$ 655.08M$ 746.00M
Cash Flow
Free Cash Flow$ 0.00$ -130.57M$ -68.07M$ -96.48M$ -68.47M
Operating Cash Flow$ 0.00$ -130.41M$ -68.00M$ -96.11M$ -68.19M
Investing Cash Flow$ 99.52M$ 122.70M$ 8.92M$ 63.46M$ -454.67M
Financing Cash Flow$ 202.53M$ 331.00K$ 628.00K$ 1.33M$ 625.53M
Currency in USD

Nuvation Bio Earnings and Revenue History

Nuvation Bio Debt to Assets

Nuvation Bio Cash Flow

Nuvation Bio Forecast EPS vs Actual EPS